newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases

Patent protects Supera-CBD, shown to be 7-8X more effective than plant-derived CBD in reducing enzymes that play a key role in pain, inflammation, and neurodegeneration MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical st